Compare GPMT & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GPMT | DXR |
|---|---|---|
| Founded | 2015 | 1970 |
| Country | United States | United States |
| Employees | 28 | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 64.7M | 59.0M |
| IPO Year | N/A | 1995 |
| Metric | GPMT | DXR |
|---|---|---|
| Price | $1.45 | $10.85 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | ★ 125.5K | 1.7K |
| Earning Date | 05-05-2026 | 02-27-2026 |
| Dividend Yield | ★ 12.99% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | ★ $1,446,345.00 |
| Revenue This Year | $458.85 | $44,935.22 |
| Revenue Next Year | $8.63 | $74.79 |
| P/E Ratio | ★ N/A | $33.83 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.24 | $8.56 |
| 52 Week High | $3.12 | $14.76 |
| Indicator | GPMT | DXR |
|---|---|---|
| Relative Strength Index (RSI) | 59.06 | 55.86 |
| Support Level | $1.39 | $9.79 |
| Resistance Level | $1.46 | $10.91 |
| Average True Range (ATR) | 0.06 | 0.40 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 73.17 | 39.78 |
Granite Point Mortgage Trust Inc focuses on directly originating, investing in, and managing senior floating rate commercial mortgage loans and other debt and debt-like commercial real estate investments. The company constructs its investment portfolio on a loan-by-loan basis, emphasizing rigorous credit underwriting, selectivity, and diversification, and assesses each investment from a fundamental value perspective relative to other opportunities available in the market. It typically provides intermediate-term bridge or transitional financing for a variety of purposes, including acquisitions, recapitalizations, refinancing, and a range of business plans, including lease-up, renovation, repositioning and repurposing of the commercial property.
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system.